Blockchain Registration Transaction Record

OKYO Pharma CEO Shares Promising Findings on Dry Eye Disease and Neuropathic Pain Treatment

OKYO Pharma CEO shares promising findings on the treatment of dry eye disease and neuropathic pain, offering hope to patients with no FDA-approved treatments available.

OKYO Pharma CEO Shares Promising Findings on Dry Eye Disease and Neuropathic Pain Treatment

This news matters as it highlights a potential breakthrough in dry eye disease and neuropathic corneal pain treatment, offering hope to patients with no FDA-approved treatments available.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0xfc0b357cd880d21a17f960e402b6887717bad952686353d14d993046b8e1cab1
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintchefwW6d-0d6ce996fedae50a5e741060d94069a4